Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting

Andrew C. Esposito, James Crawford, Elin R. Sigurdson, Elizabeth Handorf, Shelly B. Hayes, Marsha C. Boraas, Richard Bleicher

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background Breast conservation therapy (BCT) consists of breast conservation surgery (BCS) and radiotherapy (RT). Neoadjuvant chemotherapy (NACT) can downstage tumors, broadening BCS eligibility in patients requiring mastectomy. However, tumor downstaging does not obviate need for RT. This study evaluated factors that predict RT omission after NACT and BCS. Methods The National Cancer Database was queried for women with unilateral, clinical stage II-III breast cancer, treated with NACT and BCS between 2008 and 2012. Patients not receiving RT after NACT and BCS were identified. A subgroup analysis was performed eliminating patients for whom RT was recommended but not received. Results Among 10,220 patients meeting study eligibility, 974 (9.53%) did not receive RT after BCS. Predictors of RT omission included older age, insurance status, facility type, facility region, more recent year of diagnosis, receptor status unknown, human epidermal growth factor receptor 2 status positive or unknown, and positive margins. Factors increasing the likelihood of RT receipt included cN3 disease, receptor positivity, and primary downstaging. Race, Hispanicity, education, income, comorbidities, rural versus urban setting, histology, grade, and nodal stage change were not associated with RT omission. When excluding the 314 patients for whom RT was recommended but not received, age, Medicaid insurance, facility type, facility region, receptor status unknown, human epidermal growth factor receptor 2 status unknown, and positive margins were predictors of RT omission. Conclusions Race, comorbidities, and socioeconomic status were not predictors of RT omission. It remains unclear whether omission of RT in some cases is due to lack of physician knowledge. Further efforts are needed to ensure that physicians and patients recognize that RT is a vital and required part of BCT, even after NACT.

Original languageEnglish
Pages (from-to)49-57
Number of pages9
JournalJournal of Surgical Research
Volume221
DOIs
StatePublished - Jan 2018

Keywords

  • Breast Neoplasms/therapy
  • Carcinoma, Ductal, Breast/therapy
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Mastectomy, Segmental
  • Neoadjuvant Therapy
  • Radiotherapy/statistics & numerical data
  • Retrospective Studies

Fingerprint

Dive into the research topics of 'Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting'. Together they form a unique fingerprint.

Cite this